4 free views remaining today
developmental and epileptic encephalopathy 93
Description
Developmental and Epileptic Encephalopathy (DEE)
Developmental and Epileptic Encephalopathy (DEE) is a group of rare and severe epilepsies that are characterized by both seizures and significant developmental delay or loss of developmental skills. This condition typically begins in infancy or childhood and is associated with frequent seizures of multiple different types, intellectual disability, and significant developmental delay, regression, or plateau.
Key Features:
- Seizures: Frequent seizures of multiple different types, often drug-resistant
- Developmental Delay: Significant developmental delay or loss of developmental skills
- Intellectual Disability: Associated with intellectual disability in many cases
- Early-Onset: Typically begins in infancy or childhood
Causes:
- Genetic Variants: Many DEEs are related to gene variants, which can increase susceptibility to epileptic seizures and cognitive deterioration.
- Neurobiological Process: The neurobiological process behind the epilepsy also contributes to the developmental delay.
Subtypes:
- Early-Infantile Developmental and Epileptic Encephalopathy (EIDEE): A subgroup of DEE where the onset of seizures is before 3 months of age.
- Steroid-Sensitive Epileptic Encephalopathies: Conditions such as Hashimoto encephalopathy, progressive myoclonus epilepsies, and neonatal epileptic encephalopathies are not classified in this group but are worth mentioning.
References:
- [1] Developmental and Epileptic Encephalopathies (DEEs) are a heterogeneous group of disorders characterized by early-onset, often severe epileptic seizures and EEG abnormalities. [7]
- The term "developmental and epileptic encephalopathy" (DEE) refers to when cognitive functions are influenced by both seizure and interictal epileptiform activity and the neurobiological process behind the epilepsy. Many DEEs are related to gene variants and the onset is typically during early childhood. [11]
- Developmental and Epileptic Encephalopathy (DEE) refers to a group of severe epilepsies that are characterized both by seizures, which are often drug-resistant, as well as encephalopathy, which is a term used to describe significant developmental delay or even loss of developmental skills. [9]
Additional Characteristics
- Typically begins in infancy or childhood
- Frequent seizures of multiple different types, often drug-resistant
- Significant developmental delay or loss of developmental skills
- Many DEEs are related to gene variants and the onset is typically during early childhood
- When cognitive functions are influenced by both seizure and interictal epileptiform activity and the neurobiological process behind the epilepsy.
- Associated with intellectual disability in many cases
- Characterized by early-onset, often severe epileptic seizures and EEG abnormalities
- A group of rare and severe epilepsies that are characterized by both seizures and significant developmental delay or loss of developmental skills.
- Many DEEs are related to gene variants, which can increase susceptibility to epileptic seizures and cognitive deterioration.
- A subgroup of DEE where the onset of seizures is before 3 months of age.
- Conditions such as Hashimoto encephalopathy, progressive myoclonus epilepsies, and neonatal epileptic encephalopathies are not classified in this group but are worth mentioning.
- Typically begins in infancy or childhood and is associated with frequent seizures of multiple different types, intellectual disability, and significant developmental delay, regression, or plateau.
- The neurobiological process behind the epilepsy also contributes to the developmental delay.
- A group of severe epilepsies that are characterized both by seizures, which are often drug-resistant, as well as encephalopathy, which is a term used to describe significant developmental delay or even loss of developmental skills.
Signs and Symptoms
Developmental and Epileptic Encephalopathy (DEE) is a group of severe epilepsies characterized by both seizures and encephalopathy, which refers to significant developmental delay or loss of developmental skills. The symptoms of DEE can vary greatly depending on the specific syndrome experienced.
Common Symptoms:
- Frequent seizures of multiple different types
- Intellectual disability
- Significant developmental delay, regression, or plateau
- Reduced muscle tone (hypotonia)
- Hysarrhythmia (an irregular pattern seen on EEG)
- Dyskinesia (involuntary movements)
These symptoms can be present from infancy or childhood and are often associated with frequent seizures. It's essential to note that the specific symptoms can vary depending on the syndrome, but these commonalities are shared among many DEE cases.
References:
- [3] Developmental and Epileptic Encephalopathies (DEEs) are a group of rare and severe epilepsies.
- [4] Symptoms of epileptic encephalopathy vary greatly depending on the syndrome. However, several epileptic encephalopathy syndromes share symptoms, including: ...
- [8] Other signs and symptoms may include intellectual disability, reduced muscle tone (hypotonia), hypsarrhythmia (an irregular pattern seen on EEG), dyskinesia ( ...
Additional Symptoms
- Intellectual disability
- Reduced muscle tone (hypotonia)
- Significant developmental delay, regression, or plateau
- Hypsarrhythmia (an irregular pattern seen on EEG)
- Dyskinesia (involuntary movements)
Diagnostic Tests
Diagnostic Tests for Developmental and Epileptic Encephalopathy
Developmental and epileptic encephalopathy (DEE) is a severe form of epilepsy that affects both brain development and function. Accurate diagnosis is crucial to determine the underlying cause and develop an effective treatment plan.
Several diagnostic tests can help identify DEE:
- Electroencephalogram (EEG): An EEG measures the electrical activity of the brain and can detect abnormal patterns associated with DEE. Most babies with DEE1 have characteristic results on an EEG [4].
- Magnetic Resonance Imaging (MRI): MRI scans can help identify structural abnormalities in the brain that may be contributing to DEE.
- Genetic testing: Genetic testing is a powerful tool for detecting clinically significant genomic variants, such as microdeletions and duplications, which can contribute to DEE [6]. Next-generation sequencing using a panel of up to 500 genes is commonly used to identify the underlying cause of DEE [7].
- Chromosomal microarray analysis (CMA): CMA is another genetic testing method that can help detect genomic variants associated with DEE.
- Molecular testing: Molecular testing can facilitate the diagnosis of the aetiology of the DEE by identifying specific genetic mutations or other molecular abnormalities.
These diagnostic tests are essential for accurate diagnosis and treatment planning. Early diagnosis leads to earlier intervention, which can improve prognosis and potentially lead to the reversal of developmental slowing [11][12].
Additional Diagnostic Tests
- Magnetic Resonance Imaging (MRI)
- Genetic testing
- Electroencephalogram (EEG)
- Molecular testing
- Chromosomal microarray analysis (CMA)
Treatment
Treatment Options for Developmental and Epileptic Encephalopathy
Developmental and epileptic encephalopathies (DEEs) are rare and severe epilepsies that can be challenging to manage. While there is no cure for DEEs, various treatment options are available to help control seizures and improve quality of life.
Conventional Antiepileptic Drugs
Traditional antiseizure medications, such as phenobarbital, carbamazepine, and valproate, may be prescribed to manage seizures in individuals with DEEs [3]. However, these drugs often have limited efficacy and can cause significant side effects [13].
Newer Antiepileptic Drugs
More recent antiseizure medications, such as levetiracetam, topiramate, and perampanel, may be considered for patients with DEEs who do not respond to conventional treatments [15]. These newer drugs have shown promise in reducing seizure frequency and improving cognitive function.
Other Treatment Options
In addition to medication, other treatment options may include:
- Vagus Nerve Stimulation (VNS): A device that delivers electrical impulses to the brain to help control seizures.
- Ketogenic Diet: A high-fat, low-carbohydrate diet that has been shown to reduce seizure frequency in some individuals with DEEs.
- Surgery: In rare cases, surgical options may be considered for patients with focal epilepsy or other specific conditions.
Prognosis and Outcomes
The prognosis and outcomes for individuals with DEEs can vary significantly depending on the underlying cause of the condition, the severity of seizures, and the effectiveness of treatment. While some individuals may experience significant improvement with treatment, others may continue to experience frequent and severe seizures [14].
It's essential to note that each individual with DEEs is unique, and a comprehensive treatment plan should be tailored to their specific needs and circumstances.
References:
[3] C Johannessen Landmark ยท 2021 ยท Cited by 41 โ Developmental and epileptic encephalopathies (DEEs) are among the most challenging of all epilepsies to manage...
[13] For example, it is believed that treating electrical status epilepticus in sleep and other syndromes prior to major loss of function will result in better outcomes.
[14] Proper antiepileptic drug, hormonal treatment, or i.v. immunoglobulin choice play major role in prognosis.
[15] New antiepileptic drugs in pediatric epilepsy. Brain and Development. 2008;30(9):549โ555. doi: 10.1016/j.braindev.2008.01.007.
Recommended Medications
- Surgery
- Vagus Nerve Stimulation (VNS)
- Ketogenic Diet
- valproate
- Valproate
- perampanel
- phenobarbital
- Phenobarbital
- topiramate
- levetiracetam
- Levetiracetam
- carbamazepine
- Carbamazepine
๐ Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
Based on the context provided, here are some potential differential diagnoses for Developmental and Epileptic Encephalopathy (DEE):
- Early Myoclonic Encephalopathy: A rare and severe form of epilepsy characterized by myoclonic seizures, developmental delay, and encephalopathy.
- West Syndrome: Also known as infantile spasms, this is a severe form of epilepsy that typically presents in infancy, characterized by clusters of brief, shock-like muscle contractions (spasms) and developmental regression.
- Other Early-Onset Epilepsies: Such as Lennox-Gastaut syndrome, Dravet syndrome, or other rare epileptic encephalopathies.
These conditions can present with similar symptoms to DEE, such as developmental delay, intellectual disability, and seizures, making differential diagnosis crucial for accurate treatment and management.
Please let me know if you'd like me to elaborate on any of these options!
Additional Differential Diagnoses
- Other Early-Onset Epilepsies
- West syndrome
- early myoclonic encephalopathy
Additional Information
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_6784
- owl#annotatedSource
- t388627
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#id
- DOID:0112275
- core#notation
- DOID:0112275
- oboInOwl#hasDbXref
- MIM:618012
- oboInOwl#hasExactSynonym
- infantile or early childhood epileptic encephalopathy 3
- rdf-schema#label
- developmental and epileptic encephalopathy 93
- IAO_0000115
- A developmental and epileptic encephalopathy characterized by delayed psychomotor development, early-onset refractory seizures, and impaired intellectual development that has_material_basis_in heterozygous mutation in the ATP6V1A gene on chromosome 3q13.31.
- rdf-schema#subClassOf
- t388672
- IDO_0000664
- http://purl.obolibrary.org/obo/GENO_0000147
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.